Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities
Net loss	$ (1,242,777)	$ (1,320,770)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	4,596	442
Amortization	106,203	106,203
Stock-based compensation – employees	167,400	167,400
Non-cash interest expense	701,885	561,910
Non-cash interest expense – related parties	113,214	104,286
Deferred lease expense		13,576
Foreign exchange loss (gain)	24,494	(30,443)
Changes in operating assets and liabilities which provided (used) cash
Operating lease right-of-use assets	5,216
Other receivable	1,001	(146,018)
Accounts payable	(957)	14,770
Accounts payable – related parties		(7,585)
Operating lease liabilities	4,805
Accrued expenses	44,055	12,903
Net cash used in operating activities	(80,475)	(523,326)
Cash flows from investing activities
Advance on business acquisition	(30,000)
Leasehold improvements in progress		(5,439)
Net cash used in investing activities	(30,000)	(5,439)
Cash flows from financing activities
Issuance of loans payable		180,000
Repayment of loans payable		(130,000)
Issuance of loans payable – related parties		225,000
Issuance of convertible notes	147,034	595,800
Net cash provided by financing activities	147,034	870,800
Net increase in cash and cash equivalents	36,559	342,035
Cash and cash equivalents, beginning of period	3,193	84,978
Cash and cash equivalents, end of period	39,752	427,013
Supplemental cash flows disclosures
Cash paid for interest		32,593
Non-cash transactions - investing and financing activities
Patent acquisition liability modification		$ 4,380,000